Back to search

Article

Bioequivalence Evaluation of Generic Febuxostat versus Feburic ® in Healthy Chinese Subjects: A Randomized Crossover Study

2025-05-21

Abstract excerpt

<title>Abstract</title> <p><bold>Purpose</bold> Febuxostat, a xanthine oxidase inhibitor, is a first-line treatment for gout with hyperuricemia. This study evaluated the pharmacokinetic (PK) bioequivalence, safety profile, and food effects of a generic febuxostat formulation compared to the reference product (Feburic®) in healthy Chinese volunteers <bold>Patients and Methods</bold> In this randomized, open-label,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0c67d2c3-ca3a-51d5-a186-4376b704fbf1
DOI
10.21203/rs.3.rs-6492168/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Bioequivalence Evaluation of Generic Febuxostat versus Feburic ® in Healthy Chinese Subjects: A Randomized Crossover StudyDOI 10.21203/rs.3.rs-6492168/v1
Select a neighboring publication to make it the new centre.